Truist Securities Downgrades Fusion Pharmaceuticals (FUSN) to Hold

March 19, 2024 11:45 AM

Truist Securities analyst Nicole Germino downgraded Fusion Pharmaceuticals (NASDAQ: FUSN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found